// App-Quantinova.ai

2425 : Genome-wide mapping of MYCN, MYC, and MAX binding across neuroblastoma cell lines identifies novel transcriptional targets

Researchers

Presenter

  • Jo Lynne Harenza

Principal Investigators

  • Robyn Sussman

  • Derek Oldridge

  • John Maris

Medical Centers

  • Childrens Hospital of Philadelphia, Philadelphia, PA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Neuroblastoma

  • Solid malignancies

Biomarkers

  • cMYC

  • Cyclin dependent kinase 2

  • Vascular cell adhesion molecule 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved